Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

BACKGROUND: Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess the adverse drug reactions (ADRs) associated with intravenous recombinant SK in patients with AMI in routine clinical practice. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Betancourt, Blas Y, Marrero-Miragaya, María A, Jiménez-López, Giset, Valenzuela-Silva, Carmen, García-Iglesias, Elizeth, Hernández-Bernal, Francisco, Debesa-García, Francisco, González-López, Tania, Alvarez-Falcón, Leovaldo, López-Saura, Pedro A
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2005
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1291362/
https://ncbi.nlm.nih.gov/pubmed/16262910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-5-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados